Admissions in progress for all programs. Limited seats available. Apply online now All Programs are accredited by Ministry of Education, UAE. RAK College of Medical Sciences is listed in the World Directory of Medical Schools(WDOMS)

Dr. Bhoomendra Bhongade

Professor & Chairperson - Pharm.Chemistry

  • bhoomendra@rakmhsu.ac.ae


Follow on

Educational Qualification:
  • Postdoctoral Researcher, The University of West Indies, Trinidad (2006-2008) 
  • Ph.D.:  Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (2006)
  • M. Pharm.: (Pharmaceutical Chemistry), Karnatak University, Dharwad, India (1997)
  • Bachelor of Pharmacy: RTM Nagpur University, Nagpur, India (1995)  
Professional Career:
  1. Professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2019 till date)  
  2. Associate Professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (June 2014 to May 2019)  
  3. Assistant professor, Pharmaceutical Chemistry, RAK Medical & Health Sciences University, Ras Al Khaimah, UAE (Nov 2010 to May 2014)  
  4. Lecturer in Pharmaceutical Chemistry, School of Pharmacy and Health Sciences, International Medical University, Kuala Lumpur, Malaysia (Aug 2008- Nov 2010) 
  5. Postdoctoral Researcher, Department of Chemistry, The University of West Indies, Trindad, (Nov 2006- June 2008)
  6. Assistant Professor, Institute of Pharmaceutical Education & Research, Wardha, India (Oct 2005-August 2006) 
  7. Lecturer in Pharmaceutical Chemistry, Anuradha College of Pharmacy, Chikhli, MS, India (Jan 1998-Jan 2001) 
  8. CSIR Research Fellow, KLE College of Pharmacy, Belgaum, India (Jan 2002-04) 
  9. Research Assistant, KLE College of Pharmacy, Belgaum, India (Jan 2001-June 2001 and Mar 1997-Dec 1997)
Achievements/ Research Interests/ Publications /Awards Achievements:
Patents:
  1. G. Singh, P.J. Plaza, B.A. Bhongade. Synthesis and use of chiral ionic liquids. United States Patent, US8,788,689 B1, July 15, 2014
Review Reports: 
  1. Balaji Venkataraman, Shreesh Ojha, Prasanna D. Belur, Bhoomendra Bhongade, Vishnu Raj, Peter D. Collin, Thomas E. Adrian, Sandeep B. Subramanya. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases. Phytotherapy Research. 2020;1–20. 
  2. B. A. Bhongade, S. Talath, R. A. Gadad, A. K. Gadad, Biological Activities of Imidazo[2,1-b][1,3,4]thiadiazole Derivatives: A Review. J. Saudi Chem. Soc. 2016, 20(S1), S463-S475. 
  3. Imtiyaz Ahmed M. Khazi, Andanappa K. Gadad, Ravi S. Lamani and Bhoomendra A. Bhongade, Chemistry of imidazo[2,1-b][1,3,4]thiadiazoles (Report), Tetrahedron, 2011, 67, 3289-3316.
Selected Research Publications: 
  1. Bhoomendra A. Bhongade, Sunil R. Dhaneshwar, Diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) application in pharmaceutical analysis: Method for quantification of ranolozine in Tablet dosage form. Vibrational Spectroscopy, 2017, 93: 52-56.
  2. Nikhil D. Amnerkar, Bhoomendra A. Bhongade, Kishor P. Bhusari. Synthesis and biological evaluation of some 4-(6-subatituted-1,3-benzothiazole-2-yl)amino-13-thiazole-2-amines and their Schiff bases. Arabian Journal of Chemistry, 2015, 8, 545-552. 
  3. Bhoomendra A. Bhongade, Nikhil D. Amnerkar, Sirajunisa Talath, Kishor P. Bhusari and Andanappa K. Gadad, 3D-QSAR studies on isocoumarine-based urokinase-type plasminogen activator (uPA) inhibitors employing linear and non-linear regression analysis methods. Lett. Drug Des. Discov. 2012, 9, 874-880. 
  4. Bhoomendra A. Bhongade and Andanappa K. Gadad. Insight into the Structural Requirements of Urokinase Plasminogen Activator (uPA) Inhibitors based on 3D-QSAR Models. Journal of Medicinal Chemistry, 2006, 49(2), 475-89. 
  5. B. A. Bhongade and A. K. Gadad. 3D-QSAR CoMFA/CoMSIA studies on Urokinase Plasminogen Activator (uPA) Inhibitors: A Strategic Design in Novel Anticancer Agents. Bioorganic and Medicinal Chemistry, 2004, 12 (10), 2797-2805.
Awards:
  • Senior Research Fellowship, Council of Scientific & Industrial Research (CSIR), New Delhi, India (2002-2005)
Research Interests:
  • Chiral drug (intermediate) synthesis
  • Computer aided-drug design, Molecular modelling, 3D-QSAR, Molecular docking.
  • Design and synthesis of small molecule as selective inhibitors of enzyme targets involved cancer, microbial and viral infection.   
  • Development and validation of FTIR spectroscopic method for the quantification of pharmaceuticals.
Profile URL: